Low Indoleamine 2,3-Dioxygenase 1 Expression Enhances Dendritic Cells Response to Tumor Cells Against Hepatocellular Carcinoma. [PDF]
Mo C +5 more
europepmc +1 more source
Enhanced tryptophan-kynurenine metabolism via indoleamine 2,3-dioxygenase 1 induction in dermatomyositis. [PDF]
Wu D +13 more
europepmc +1 more source
Immunotherapy is emerging as promising new approach for cancer therapy, with the first immunotherapy agents recently approved by the FDA, and many more in clinical development.
Van den Eynde, Benoît +1 more
core
Phosphorylation of ITIM motifs drives the structural transition of indoleamine 2,3-dioxygenase 1 between enzymatic and non-enzymatic states. [PDF]
Hoffka G +3 more
europepmc +1 more source
Rational design of indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors featuring 1,2,3-triazole derivatives with enhanced anti-inflammatory and analgesic efficacy. [PDF]
Liu Q +6 more
europepmc +1 more source
Interleukin-6 promotes skeletal muscle catabolism by activating tryptophan-indoleamine 2,3-dioxygenase 1-kynurenine pathway during intra-abdominal sepsis. [PDF]
Xie T +10 more
europepmc +1 more source
Photoresponsive prodrug for regulated inhibition of indoleamine 2,3-dioxygenase 1 enzyme activity. [PDF]
Das NM +8 more
europepmc +1 more source
HDLR-SR-BI Expression and Cholesterol Uptake are Regulated via Indoleamine-2,3-dioxygenase 1 in Macrophages under Inflammation. [PDF]
Chini A +8 more
europepmc +1 more source
Indoleamine 2,3-dioxygenase 1 promotes osteosarcoma progression by regulating tumor-derived exosomal miRNA hsa-miR-23a-3p. [PDF]
Yang D +10 more
europepmc +1 more source
Indoleamine 2,3-dioxygenase 1 alters the proportions of B cell subpopulations in the microenvironment of acute myeloid leukemia. [PDF]
Yao Y +7 more
europepmc +1 more source

